Neuropore Therapies chooses INTEGRA pipettes to accelerate its research

California-based drug discovery company Neuropore Therapies is using INTEGRA Biosciences’ EVOLVE, VIAFLO and VOYAGER pipettes to help accelerate research in both its in vitro and in vivo pharmacology departments. The company, which is dedicated to halting the progression of neurodegenerative diseases by targeting the core processes underlying these disorders, has been a long term supporter of INTEGRA, as a Neuropore scientist explained...

Original Article: Neuropore Therapies chooses INTEGRA pipettes to accelerate its research

More From BioPortfolio on "Neuropore Therapies chooses INTEGRA pipettes to accelerate its research"